These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8556718)

  • 1. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal.
    Jassem J; Bartelink H
    Cancer Treat Rev; 1995 Sep; 21(5):447-62. PubMed ID: 8556718
    [No Abstract]   [Full Text] [Related]  

  • 2. Is induction chemotherapy the new standard in organ preservation treatment for locally advanced head and neck cancer in 2010?
    Porceddu SV
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):75-6. PubMed ID: 20565417
    [No Abstract]   [Full Text] [Related]  

  • 3. Organ preservation for advanced head and neck cancer concomitant chemoradiation.
    Brockstein B
    Cancer Treat Res; 2003; 114():235-48. PubMed ID: 12619544
    [No Abstract]   [Full Text] [Related]  

  • 4. A new look at induction chemotherapy in locally advanced head and neck cancer.
    Vermorken JB
    Oncologist; 2010; 15 Suppl 3():1-2. PubMed ID: 21036881
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy in head and neck cancer.
    Armand JP; Couteau C
    Eur J Cancer; 1995; 31A(5):819-22. PubMed ID: 7640066
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced head and neck cancer: what lessons have we learned?
    Conley BA
    J Clin Oncol; 2006 Mar; 24(7):1023-5. PubMed ID: 16505419
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant and neoadjuvant treatment of head and neck cancers.
    Jacobs C
    Semin Oncol; 1991 Dec; 18(6):504-14. PubMed ID: 1775969
    [No Abstract]   [Full Text] [Related]  

  • 8. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
    Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
    Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
    Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
    Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
    [No Abstract]   [Full Text] [Related]  

  • 10. In regard to Suntharalingam et al. IJROBP 2000;47(1):49-56.
    Ochel H
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):281-2. PubMed ID: 11163527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 13. New concepts in radiotherapy for advanced squamous cell carcinoma of the head and neck.
    Poulsen MG
    Aust N Z J Surg; 1992 Sep; 62(9):702-8. PubMed ID: 1520152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
    Hong WK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction chemotherapy for squamous cancer of the head and neck.
    Kies MS
    Curr Oncol Rep; 2007 Mar; 9(2):129-33. PubMed ID: 17288879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in radiochemotherapy in the treatment of head and neck cancer.
    Herchenhorn D; Dias FL
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Jan; 59(1):39-46. PubMed ID: 15029284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
    Herchenhorn D; Ferreira CG
    J Clin Oncol; 2011 Apr; 29(10):e283-4; author reply e285-7. PubMed ID: 21300921
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
    Ohashi T; Ohnishi M; Tanahashi S; Murai M
    Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.